xRead - September 2022

Wise et al.

Page 393

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

AR = allergic rhinitis; BID = 2 times daily; DBRCT = double-blind randomized controlled trial; LOE = level of evidence; PAR = perennial allergic rhinitis; QOL = quality of life; Rcq-36 = rhinoconjunctivitis QOL questionnaire; RCT = randomized controlled trial; SAR = seasonal allergic rhinitis; SBRCT = single-blind randomized controlled trial; SR = systematic review; TID = 3 times daily; TNSS = Total Nasal Symptom Score.

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.